February 18, 2025

Arcus Biosciences Advances Promising Kidney Cancer Drug Casdatifan After Gilead Opts Out

2 months ago talkbio0Tagged Arcus, casdatifan, cell renal cell carcinoma, Clinical Trials, Conventional (Clear Cell) Renal Cell Carcinoma, HIF-2a, Inhibitor, Malignant neoplasm of kidney

Arcus Biosciences, casdatifan, HIF-2a inhibitor, kidney cancer, clear cell renal cell carcinoma (ccRCC), Gilead Sciences, clinical trial data, $150 million stock offering

FDA Approves Ono’s Romvimza for Rare Joint Tumor, Challenging Daiichi Sankyo’s Turalio

2 months ago talkbio0Tagged Approved, CSF1, CSF1 gene, Daiichi, Dosage Forms, Fibrous histiocytoma of tendon sheath, Giant Cell Tumors, Inhibitor, Joint Tumor, Romvimza, Sankyo, tenosynovial, Turalio, United States Food and Drug Administration, Vimseltinib

Romvimza, vimseltinib, tenosynovial giant cell tumor (TGCT), Ono Pharmaceutical, FDA approval, Daiichi Sankyo, Turalio, CSF1 inhibitor, rare joint tumor

Biotech Breakthroughs 2025: Emerging Trends and Technologies Shaping the Industry’s Future

2 months ago talkbio0Tagged Aortic Valve Insufficiency, Cancer Vaccines, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Drug Discovery, Gene Modification, Investments, personalized therapies, Platform technologies, Precision Medicine, solid-state batteries

CRISPR therapeutics, solid-state batteries, precision medicine, AI in drug discovery, gene editing, cancer vaccines, personalized therapies, biotech investment, platform technologies, clinical trial innovation

Heartbeat Chronicles: Inspiring Stories and Breakthroughs in Cardiovascular Health

2 months ago talkbio0Tagged cardiac research, Cardiovascular system, Heart Diseases, heart health, medical advancements

Heart disease, patient stories, medical advancements, cardiac research, heart health, cardiovascular breakthroughs

GSK’s Penmenvy Gains FDA Approval, Joining Pfizer in 5-in-1 Meningococcal Vaccine Market

2 months ago talkbio0Tagged Adolescent (age group), Approved, Invasive meningococcal disease, Meningococcal vaccine, Penmenvy, Pfizer, SmithKline Beecham, United States Food and Drug Administration, Vaccines, Young Adult

Penmenvy, GSK, FDA approval, meningococcal vaccine, 5-in-1 vaccine, Pfizer, Penbraya, invasive meningococcal disease (IMD), adolescents and young adults

Massive Layoffs Sweep Federal Health Agencies: Thousands of Workers Impacted Across HHS

2 months ago talkbio0Tagged Administration occupational activities, Centers for Disease Control and Prevention (U.S.), federal, Health agencies, HHS layoffs, Myasthenic Syndromes, Congenital, NIH, NIH Mouse, probationary workers, Transplant Registry Unified Management Program, United States Food and Drug Administration

HHS layoffs, federal health agencies, probationary workers, Trump administration, workforce reduction, CDC, NIH, FDA, CMS

Septerna Halts Phase 1 Trial of SEP-786 Due to Unexpected Bilirubin Elevations

2 months ago talkbio0Tagged Agonist, Bilirubin, Clinical Trials, Discontinuation (procedure), Hypoparathyroidism, PTH1R gene, SEP-786, Septerna

Septerna, SEP-786, clinical trial discontinuation, hypoparathyroidism, bilirubin elevation, PTH1R agonist, biotech setback

Trump Establishes Make America Healthy Again Commission to Combat Childhood Chronic Diseases

2 months ago talkbio0Tagged CHARGE Syndrome, Chronic disease, Commission, disease prevention, MAHA, public health medicine (field), Robert F. Kennedy Jr., Secretary

MAHA Commission, Robert F. Kennedy Jr., childhood chronic diseases, HHS Secretary, Executive Order, public health, chronic illness, disease prevention

Mass Layoffs at HHS: Trump Administration Cuts Thousands of Probationary Workers

2 months ago talkbio0Tagged Administration occupational activities, Centers for Disease Control and Prevention (U.S.), HHS layoffs, NIH Mouse, public health medicine (field), Transplant Registry Unified Management Program, United States Food and Drug Administration, Workers

HHS layoffs, probationary employees, Trump administration, CDC, NIH, FDA, federal workforce reduction, public health impact